Skip to main content
. 2020 Sep 29;12(10):2796. doi: 10.3390/cancers12102796

Table 2.

Mutational characteristics of the whole dataset.

Mutation Status n = 288 (100%)
BRAF a n = 96 (33.3%)
NRAS b n = 62 (21.5%)
Focal positivity for NRAS b c n = 5 (1.8%)
BRAF and NRAS negative n = 124 (43%)
Positive IHC for BRAF and NRAS n = 1 (0.4%)

a: BRAF mutations V600E or V600K; b: NRAS mutations Q61R or K or L or H; c: one sample is defined with focal positivity (−/+) by IHC and four both through IHC and ddPCR (0.08 or 0.16 copies/μL).